We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$66B
AUM Growth
+$2.8B
Cap. Flow
-$821M
Cap. Flow %
-1.25%
Top 10 Hldgs %
19.49%
Holding
4,235
New
202
Increased
1,749
Reduced
2,003
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 12.45%
2 Financials 5.29%
3 Consumer Discretionary 3.99%
4 Healthcare 3.91%
5 Industrials 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTS icon
3951
Intensity Therapeutics
INTS
$12M
$40K ﹤0.01%
417
IMMX icon
3952
Immix Biopharma
IMMX
$607M
$39K ﹤0.01%
26,080
LUNA
3953
DELISTED
Luna Innovations Incorporated
LUNA
$39K ﹤0.01%
16,592
BCAB icon
3954
BioAtla
BCAB
$5.59M
$38K ﹤0.01%
436
TELA icon
3955
TELA Bio
TELA
$30.9M
$38K ﹤0.01%
14,886
GUT.RT
3956
DELISTED
The Gabelli Utility Trust Rights (expiring October 21, 2024)
GUT.RT
$37K ﹤0.01%
+1,335,245
New +$36.9K
FCEL icon
3957
FuelCell Energy
FCEL
$1.7B
$36K ﹤0.01%
3,129
-453
-13% -$6.71K
TARA icon
3958
Protara Therapeutics
TARA
$226M
$36K ﹤0.01%
19,428
UBX
3959
DELISTED
Unity Biotechnology
UBX
$35K ﹤0.01%
24,112
-500
-2% -$734
ATAI icon
3960
AtaiBeckley Inc
ATAI
$2.66B
$34K ﹤0.01%
29,157
-1,018
-3% -$1.36K
AXTI icon
3961
AXT Inc
AXTI
$3.09B
$34K ﹤0.01%
14,100
-100
-0.7% -$283
GOSS icon
3962
Gossamer Bio
GOSS
$66.5M
$34K ﹤0.01%
34,471
+3,300
+11% +$3.17K
VYNE icon
3963
VYNE Therapeutics
VYNE
$340K
$34K ﹤0.01%
+18,298
New +$34.7K
BARK icon
3964
BARK
BARK
$74.8M
$33K ﹤0.01%
1,008
DYAI icon
3965
Dyadic International
DYAI
$43.4M
$33K ﹤0.01%
32,164
+1,000
+3% +$1.33K
OKUR
3966
OnKure Therapeutics
OKUR
$166M
$33K ﹤0.01%
1,935
ESPR
3967
DELISTED
Esperion Therapeutics
ESPR
$32K ﹤0.01%
19,237
GNLX icon
3968
Genelux
GNLX
$130M
$32K ﹤0.01%
13,567
+455
+3% +$1K
IAUX
3969
i-80 Gold Corp
IAUX
$1.17B
$32K ﹤0.01%
27,715
+2,270
+9% +$2.38K
PRPH
3970
DELISTED
ProPhase Labs
PRPH
$32K ﹤0.01%
1,336
UROY
3971
Uranium Royalty Corp
UROY
$434M
$32K ﹤0.01%
13,149
DDD icon
3972
3D Systems Corp
DDD
$420M
$31K ﹤0.01%
10,835
+85
+0.8% +$244
TGB
3973
Trekor Metals
TGB
$2.56B
$31K ﹤0.01%
12,219
-5,345
-30% -$11.9K
WTI icon
3974
W&T Offshore
WTI
$545M
$30K ﹤0.01%
13,781
+2
+0% +$4
ALXO icon
3975
ALX Oncology
ALXO
$273M
$29K ﹤0.01%
+15,840
New +$58.9K

Similar funds

Commonwealth Equity Services's Q3 2024 Portfolio in Review

As of Q3 2024, Commonwealth Equity Services held 4,235 positions worth $66B, up 4.4% from $63.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services's Q3 2024 filing shows 202 new, 1,749 increased, 2,003 reduced and 180 closed positions. Its largest new stake was Innovator Equity Defined Protection ETF - 6mo Jan/Jul: 340,869 shares worth $9.09M. The largest sale was Apple, an estimated $106M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Commonwealth Equity Services's largest Q3 2024 buy was Innovator Equity Defined Protection ETF - 6mo Jan/Jul: 340,869 shares worth $9.09M.
  • Commonwealth Equity Services added most to Capital Group Dividend Value ETF in Q3 2024, an estimated $39M increase.
  • Commonwealth Equity Services's biggest Q3 2024 reduction was Apple, cutting an estimated $106M.
  • Commonwealth Equity Services fully exited Innovator 20+ Year Treasury Bond 5 Floor ETF July in Q3 2024, selling an estimated $17.4M.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $66B portfolio in Q3 2024.
  • Commonwealth Equity Services opened 202 new positions and closed 180 in Q3 2024.
  • Commonwealth Equity Services's portfolio value rose 4.4% quarter-over-quarter to $66B.

Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.